Skip to main content

MoneyWorks4Me

Caplin Point Laboratories informs about audited financial results

28 May 2018 Evaluate

Caplin Point Laboratories has informed about Audited Financial results for the quarter and year ended March 31, 2018 and recommendation of dividend for the financial year ended March 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..